KYORIN Pharmaceutical Co., Ltd. (KYRNF)
KYORIN Pharmaceutical Market Cap : 592.33M for May 14, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 52.52B |
| Daiichi Sankyo Co., Ltd. | 29.59B |
| Eisai Co., Ltd. | 8.389B |
| Chugai Pharmaceutical Co., Ltd. | 84.13B |
| Santen Pharmaceutical Co., Ltd. | 3.828B |
Market Cap Related Metrics
| PE Ratio | 25.55 |
| PS Ratio | 0.7078 |
| Price to Book Value | 0.6616 |
| Price | 10.31 |
| Earnings Yield | 3.91% |
| Operating PE Ratio | 24.75 |